UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Ametek
AME
|
+$778M |
| 2 |
Microsoft
MSFT
|
+$432M |
| 3 |
Amazon
AMZN
|
+$423M |
| 4 |
Apple
AAPL
|
+$190M |
| 5 |
Prologis
PLD
|
+$168M |
Top Sells
| 1 |
Amgen
AMGN
|
+$759M |
| 2 |
Accenture
ACN
|
+$510M |
| 3 |
ConocoPhillips
COP
|
+$381M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$324M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$310M |
Sector Composition
| 1 | Technology | 25.01% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.72% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Kinetik
KNTK
$2.58B
| $437K | ﹤0.01% |
13,200
| – | – |
|
2177
Corsair Gaming
CRSR
$930M
| $436K | ﹤0.01% |
32,159
| – | – |
|
|
INBX
2178
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $435K | ﹤0.01% |
+17,638
| New | +$435K |
|
2179
Atea Pharmaceuticals
AVIR
$251M
| $433K | ﹤0.01% |
90,068
+2,620
| +3% | +$12.6K |
|
2180
PetMed Express
PETS
$58.7M
| $427K | ﹤0.01% |
24,146
| – | – |
|
2181
Vimeo
VMEO
$797M
| $427K | ﹤0.01% |
124,470
+19,935
| +19% | +$68.4K |
|
2182
Veru
VERU
$50.8M
| $426K | ﹤0.01% |
8,075
+738
| +10% | +$39K |
|
2183
Microvision
MVIS
$343M
| $426K | ﹤0.01% |
181,371
| – | – |
|
2184
Fluence Energy
FLNC
$888M
| $425K | ﹤0.01% |
+24,800
| New | +$425K |
|
2185
Arcellx
ACLX
$4B
| $424K | ﹤0.01% |
+13,700
| New | +$424K |
|
2186
IonQ
IONQ
$13.1B
| $424K | ﹤0.01% |
123,014
| – | – |
|
2187
Senseonics Holdings
SENS
$362M
| $424K | ﹤0.01% |
411,338
| – | – |
|
2188
Sangamo Therapeutics
SGMO
$157M
| $419K | ﹤0.01% |
133,554
| – | – |
|
2189
Evolus
EOLS
$478M
| $418K | ﹤0.01% |
55,661
+20,151
| +57% | +$151K |
|
2190
Kimbell Royalty Partners
KRP
$1.27B
| $418K | ﹤0.01% |
+25,020
| New | +$418K |
|
2191
nLIGHT
LASR
$1.45B
| $418K | ﹤0.01% |
41,192
| – | – |
|
2192
Opko Health
OPK
$1.12B
| $418K | ﹤0.01% |
334,071
| – | – |
|
|
VERV
2193
DELISTED
Verve Therapeutics
VERV
| $413K | ﹤0.01% |
21,355
-6,147
| -22% | -$119K |
|
|
ITOS
2194
DELISTED
iTeos Therapeutics
ITOS
| $413K | ﹤0.01% |
+21,137
| New | +$413K |
|
2195
Dr. Reddy's Laboratories
RDY
$12.1B
| $411K | ﹤0.01% |
39,735
| – | – |
|
2196
Alkami Technology
ALKT
$2.66B
| $409K | ﹤0.01% |
28,026
| – | – |
|
2197
REV Group
REVG
$3.03B
| $407K | ﹤0.01% |
32,254
-301
| -0.9% | -$3.8K |
|
|
MMAT
2198
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $406K | ﹤0.01% |
3,415
-2,021
| -37% | -$241K |
|
2199
Codexis
CDXS
$221M
| $406K | ﹤0.01% |
87,084
+8,144
| +10% | +$38K |
|
|
TPC
2200
Tutor Perini Corporation
TPC
$3.19B
| $406K | ﹤0.01% |
53,744
| – | – |
|